新产品·新技术信息

Vencorex提出长期战略目标来加强脂肪族异氰酸酯的业务

来源：林中祥胶粘剂技术信息网2014年03月06日

阅读次数：次

Vencorex Presents Long Term Strategic Ambition to Reinforce Aliphatic Isocyanates Business

Vencorex presents its long term strategic ambition. This strategy is based on focusing its activities toward specialty isocyanates. (HDI, IPDI, derivatives and new products).

Vencorex objective is to strengthen its worldwide position in Aliphatic Isocyanates business. (HDI, IPDI, Tolonate & Easaqua grades and new products).

To achieve this long term ambition, Vencorex plans to enhance its footprint on production capabilities, commercial activities and R&D innovation towards the following configuration.

Tolonate production facilities in 3 main continents ready to serve global market. Vencorex already has these at Pont De Claix, France and Freeport, TX USA, with an additional facility being implemented in Thailand, starting in 2015.

Pont De Claix will continue to be the production hub of HDI and IPDI monomers with significantly larger capacity and expansion in new products.

The global Sales & Marketing organization will be strengthened to capture growth opportunities and better serve international customers.

R&D capabilities in France to be further developed to support this strategy through the innovation of new products and applications.

With all these initiatives, Vencorex will therefore implement several industrial projects with the objective to sustain its position as among the leading global partners for specialty isocyanates in the coming years.

Vencorex strategic ambition is supported by both shareholders: PTTGC and Perstorp.